Sintx Technologies, Inc. (NASDAQ:SINT – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 32,400 shares, an increase of 84.1% from the May 15th total of 17,600 shares. Based on an average daily trading volume, of 301,600 shares, the days-to-cover ratio […]
Nemaura Medical (NASDAQ:NMRD – Get Rating) and Sintx Technologies (NASDAQ:SINT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Profitability This table compares Nemaura Medical and Sintx Technologies’ […]
Sintx Technologies (NASDAQ:SINT – Get Rating) and Nemaura Medical (NASDAQ:NMRD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Earnings & Valuation This table compares Sintx Technologies and […]
Sintx Technologies, Inc. (NASDAQ:SINT – Get Rating) was the target of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 32,200 shares, a decrease of 60.1% from the March 31st total of 80,800 shares. Based on an average daily volume of 740,800 shares, the […]
Arch Therapeutics (OTCMKTS:ARTH – Get Rating) and Sintx Technologies (NASDAQ:SINT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings and valuation. Volatility and Risk Arch Therapeutics has a beta of […]